LIAISON® XL HCG
Beta human chorionic gonadotropin (beta-hCG) - tumor marker / congenital disorders · class III · Until 17/08/2036
- Registration no.
- 10339840405
- Process no.
- 25351188876201439
- Status
- Until 17/08/2036
- Device type
- Beta human chorionic gonadotropin (beta-hCG) - tumor marker / congenital disorders (BETA GONADOTROFINA CORIÔNICA HUMANA (BHCG) - RASTREAMENTO, DIAGNÓSTICO OU ESTADIAMENTO DE CÂNCER/DESORDENS CONGÊNITAS)
- Risk class
- III
- Registration holder
- DIASORIN LTDA CNPJ 01.896.764/0001-70 · 567 registrations
- Manufacturer
- Published
- 28/07/2014
- Valid until
- 17/08/2036
- Last updated by ANVISA
- 2026-10-12
- Official record
- View on ANVISA ↗